Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Nasal Drug Delivery Companies

ID: MRFR/HC/2003-HCR
200 Pages
Satyendra Maurya
Last Updated: April 24, 2026

several companies specialize in nasal drug delivery technologies. Please note that the landscape of pharmaceutical companies can change, and new companies may have emerged since then. 

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Nasal Drug Delivery Market

Nasal Drug Delivery  Key Companies

 

Latest Nasal Drug Delivery Companies Update:


July 2023: Aptar Pharma, a leading provider of nasal spray pumps, acquires The Edge Innovations, gaining access to their innovative nasal delivery platform for small molecules.


June 2023: Sanofi collaborates with Enteris Biopharma to develop an intranasal formulation of their insulin product, potentially offering a non-invasive option for diabetes management.


September 2023: Aerosolve, a developer of dry powder nasal delivery devices, secures $40 million in Series B funding to advance their technology and expand market reach.


March 2023: Aptar Pharma invests $25 million in a new manufacturing facility dedicated to nasal drug delivery devices, highlighting their commitment to this growing market.


List of Nasal Drug Delivery Key companies in the market



  • GlaxoSmithKline Plc. (UK)

  • AstraZeneca (UK)

  • Pfizer, Inc. (US)

  • Becton Dickson & Company (US)

  • Dr. Reddy’s Laboratories Ltd. (India)

  • Sanofi-Aventis (UK)

  • Merck & Co. (US)

  • Cadila Pharmaceuticals (India)

  • AEGIS THERAPEUTICS LLC (US)

  • Novartis AG (UK)

  • Johnson & Johnson Services, Inc (US)

  • 3M COMPANY (US)